Truist initiated coverage of Globant (GLOB) with a Hold rating and $72 price target Globant is taking decisive steps to transition its business model as GenAI reshapes the industry and currently trades at trough multiples reflecting slowing revenue growth, the analyst tells investors in a research note. A more constructive view would emerge with evidence that its AI pods can drive growth re-acceleration while sustaining healthy margins and cash flow, Truist says.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLOB:
- Globant and FIFA sign expanded partnership for digital services
- Astera initiated, Nasdaq upgraded: Wall Street’s top analyst calls
- Globant downgraded to Hold from Buy at Jefferies
- Cautious Hold on Globant SA Amidst Growth Challenges and Market Uncertainties
- Globant price target lowered to $70 from $75 at UBS